TB in India: Incidence, Mortality, Treatment Success and State Ranking
Why in the news
New data showed India’s TB cases and deaths falling, but poor results for drug-resistant TB and heavy household health costs.
Key facts
- Incidence: under 200 per lakh in 2022, versus 237 per lakh in 2015 (16% lower).
- Mortality: 23 per lakh in 2022, 18% lower than 2015.
- Treatment success is rising in every category.
Treatment success by type
| TB type | Success rate |
|---|---|
| MDR/RR-TB (multidrug or rifampicin resistant) | 74% |
| Pre-XDR-TB (MDR-TB plus fluoroquinolone resistance) | 68% |
| Severely drug-resistant TB (widest resistance) | 45%, lowest |
TB Index of States
- Best major States: Himachal Pradesh, Odisha, Gujarat.
- Weakest: Punjab, Bihar, Karnataka.
Concerns
- Over 10% of Indians bear catastrophic health expenditure (above 10% of household income); third highest among 14 lower-middle-income, high-TB countries.
- About 60% are covered by health insurance, yet many households still face steep costs.
Exam angle
- Lowest success: severely drug-resistant TB, 45%.